One of the keys to this therapy from my understanding is in previous animal tests the therapy activated the immune system to recognise and attack the cancer once reintroduced back into the animal model.
It looks incredibly promising in combo with IMU's OnCARlytics IMO.
GLTAH & IMO
AFR - Why analysts love these eight medtech stocks, page-4
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $128.6M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.5¢ | 12.0¢ | $87.41K | 722.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 427991 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 294321 | 6 |
View Market Depth
| Last trade - 14.58pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
12.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 12.0¢ | 12.5¢ | 12.0¢ | 285800 | ||
| Last updated 15.28pm 06/06/2024 ? | |||||
| ALA (ASX) Chart |